These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9753630)

  • 1. The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of Batten disease.
    Croopnick JB; Choi HC; Mueller DM
    Biochem Biophys Res Commun; 1998 Sep; 250(2):335-41. PubMed ID: 9753630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of Batten disease with the yeast Saccharomyces cerevisiae.
    Pearce DA; Sherman F
    Mol Genet Metab; 1999 Apr; 66(4):314-9. PubMed ID: 10191120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis.
    Gachet Y; Codlin S; Hyams JS; Mole SE
    J Cell Sci; 2005 Dec; 118(Pt 23):5525-36. PubMed ID: 16291725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of BTN1, the yeast orthologue of the gene mutated in Batten disease.
    Pearce DA; Ferea T; Nosel SA; Das B; Sherman F
    Nat Genet; 1999 May; 22(1):55-8. PubMed ID: 10319861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BTN1, a yeast gene corresponding to the human gene responsible for Batten's disease, is not essential for viability, mitochondrial function, or degradation of mitochondrial ATP synthase.
    Pearce DA; Sherman F
    Yeast; 1997 Jun; 13(8):691-7. PubMed ID: 9219333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells.
    Vitiello SP; Wolfe DM; Pearce DA
    Hum Mol Genet; 2007 May; 16(9):1007-16. PubMed ID: 17341489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein.
    Mitchison HM; Taschner PE; Kremmidiotis G; Callen DF; Doggett NA; Lerner TJ; Janes RB; Wallace BA; Munroe PB; O'Rawe AM; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):12-4. PubMed ID: 9151311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of pH regulation by Btn1p, the yeast homolog of human Cln3p.
    Pearce DA; Nosel SA; Sherman F
    Mol Genet Metab; 1999 Apr; 66(4):320-3. PubMed ID: 10191121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A yeast model for the study of Batten disease.
    Pearce DA; Sherman F
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6915-8. PubMed ID: 9618513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-species homology of the CLN3 gene.
    Taschner PE; de Vos N; Breuning MH
    Neuropediatrics; 1997 Feb; 28(1):18-20. PubMed ID: 9151313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BTN1, the Saccharomyces cerevisiae homolog to the human Batten disease gene, is involved in phospholipid distribution.
    Padilla-López S; Langager D; Chan CH; Pearce DA
    Dis Model Mech; 2012 Mar; 5(2):191-9. PubMed ID: 22107873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease.
    Kim Y; Ramirez-Montealegre D; Pearce DA
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15458-62. PubMed ID: 14660799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLG1, a new cyclin-like gene of Saccharomyces cerevisiae.
    Matsumoto Y; Wickner RB
    Yeast; 1993 Aug; 9(8):929-31. PubMed ID: 8212900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
    Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disrupted homologue of the human CLN3 or juvenile neuronal ceroid lipofuscinosis gene in Saccharomyces cerevisiae: a model to study Batten disease.
    Guo WX; Mao C; Obeid LM; Boustany RM
    Cell Mol Neurobiol; 1999 Oct; 19(5):671-80. PubMed ID: 10384264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesylation of Batten disease CLN3 protein.
    Pullarkat RK; Morris GN
    Neuropediatrics; 1997 Feb; 28(1):42-4. PubMed ID: 9151320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
    Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
    Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence of the open reading frame of the FLO1 gene from Saccharomyces cerevisiae.
    Teunissen AW; Holub E; van der Hucht J; van den Berg JA; Steensma HY
    Yeast; 1993 Apr; 9(4):423-7. PubMed ID: 8511970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic reversal of the btn1 defects in yeast by chloroquine: a yeast model for Batten disease.
    Pearce DA; Carr CJ; Das B; Sherman F
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11341-5. PubMed ID: 10500178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.